Test a new pulsed-field catheter procedure for atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests a new pulsed-field device used during an atrial fibrillation (AF) catheter ablation, aiming to improve safety and effectiveness. It’s for people who have AF and are planning an AF ablation procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with atrial fibrillation within the past 12 months
- You are planning a catheter ablation for AF
- You are 18 to 75 years old
- You have not had any prior ablation in the left or right atrium
- You do not have major heart or health issues that prevent the procedure (for example, serious heart failure, recent heart attack, or significant heart valve problems)
- You are not currently in the ICU and do not have an active whole-body infection (sepsis)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study tests a new catheter system, called Varipulse, to see if it's safe and effective for treating atrial fibrillation (AF), a heart rhythm problem. People with short-lasting AF who haven't been helped by medication may be able to join.
This trial tests a new method called pulsed field ablation to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to safely stop AF episodes by targeting specific areas in the heart, and may help people with paroxysmal (coming and going) or persistent AF who haven't had this procedure before.
This study follows patients who are already scheduled to receive a specific heart rhythm treatment called Globe pulsed field ablation for atrial fibrillation (an irregular heartbeat condition). Researchers will track how well the procedure works and how patients do afterward.
This study tests a new type of catheter ablation (a procedure that uses energy to treat irregular heartbeats) for atrial fibrillation—a common heart rhythm problem. You may qualify if you have recurring irregular heartbeats that haven't responded well to heart medications and are planning to have this procedure.
This trial tests a new type of heart procedure called pulsed field ablation to treat an irregular heartbeat (atrial fibrillation) in people who have already had a device placed to close off a part of the heart (left atrial appendage occlusion). The goal is to see if this safer ablation method can help control your heart rhythm.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.